The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients

NCT ID: NCT00524251

Last Updated: 2008-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

990 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-06-30

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the improvement in the quality of life after an initial treatment with esomeprazole 40mg for reflux disease is the same in patients who have already made lifestyle-adjustments as in patients who have not implemented lifestyle-adjustments prior to the start of treatment (baseline)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

GERD Quality of Life

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Patients with reflux complaints GERD quality of life lifestyle adjustments

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

esomeprazole

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with reflux complaints
* 18 years of age

Exclusion Criteria

* Restrictions as mentioned in the registration text
* H2RA or PPI use in the month prior to inclusion
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

A Sellink, MD

Role: STUDY_DIRECTOR

AstraZeneca

N van den Berk

Role: STUDY_CHAIR

AstraZeneca

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

's-Gravenzande, , Netherlands

Site Status

Research Site

Almere Stad, , Netherlands

Site Status

Research Site

Apeldoorn, , Netherlands

Site Status

Research Site

Baarn, , Netherlands

Site Status

Research Site

Bennebroek, , Netherlands

Site Status

Research Site

Blaardingen, , Netherlands

Site Status

Research Site

Boekel, , Netherlands

Site Status

Research Site

Delft, , Netherlands

Site Status

Research Site

Enschede, , Netherlands

Site Status

Research Site

Ewijk, , Netherlands

Site Status

Research Site

Geleen, , Netherlands

Site Status

Research Site

Haelen, , Netherlands

Site Status

Research Site

Halfweg NH, , Netherlands

Site Status

Research Site

Hardenberg, , Netherlands

Site Status

Research Site

Heemstede, , Netherlands

Site Status

Research Site

Hillegom, , Netherlands

Site Status

Research Site

Hilversum, , Netherlands

Site Status

Research Site

Horst, , Netherlands

Site Status

Research Site

Kerkrade, , Netherlands

Site Status

Research Site

Klimmen, , Netherlands

Site Status

Research Site

Landgraaf, , Netherlands

Site Status

Research Site

Laren, , Netherlands

Site Status

Research Site

Leusden, , Netherlands

Site Status

Research Site

Lichtenvoorde, , Netherlands

Site Status

Research Site

Lisse, , Netherlands

Site Status

Research Site

Maastricht, , Netherlands

Site Status

Research Site

Monster, , Netherlands

Site Status

Research Site

Nieuw-Vennep, , Netherlands

Site Status

Research Site

Nieuwegein, , Netherlands

Site Status

Research Site

Nijverdal, , Netherlands

Site Status

Research Site

Ochten, , Netherlands

Site Status

Research Site

Oisterwijk, , Netherlands

Site Status

Research Site

Oldenzaal, , Netherlands

Site Status

Research Site

Pijnacker, , Netherlands

Site Status

Research Site

Rijnsburg, , Netherlands

Site Status

Research Site

Rijssen, , Netherlands

Site Status

Research Site

Schijndel, , Netherlands

Site Status

Research Site

Sittard, , Netherlands

Site Status

Research Site

Soest, , Netherlands

Site Status

Research Site

Spakenburg, , Netherlands

Site Status

Research Site

Susteren, , Netherlands

Site Status

Research Site

Swalmen, , Netherlands

Site Status

Research Site

The Hague, , Netherlands

Site Status

Research Site

Tilburg, , Netherlands

Site Status

Research Site

Vaals, , Netherlands

Site Status

Research Site

Valkenburg, , Netherlands

Site Status

Research Site

Veenendaall, , Netherlands

Site Status

Research Site

Velp, , Netherlands

Site Status

Research Site

Warnsveld, , Netherlands

Site Status

Research Site

Wassenaar, , Netherlands

Site Status

Research Site

Westerhaar-Vrienzenv Wijk, , Netherlands

Site Status

Research Site

Zandvoort, , Netherlands

Site Status

Research Site

Zevenhuizen, , Netherlands

Site Status

Research Site

Zoetermeer, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N11

Identifier Type: -

Identifier Source: org_study_id